Ignite Creation Date:
2024-05-05 @ 12:04 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00234546
Status:
COMPLETED
Last Update Posted:
2019-07-26
First Post:
2005-10-06
Brief Title:
Asian Botulinum Clinical Trial Designed for Early Stroke Spasticity
Sponsor:
Ipsen
Organization:
Ipsen
Study Overview
Official Title:
A 24-week Prospective Multicentre Randomised Double-blind Placebo Controlled Study of Dysport Injection for the Treatment of Upper Limb Spasticity in Early Stroke
Status:
COMPLETED
Status Verified Date:
2019-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this clinical study is to investigate the efficacy and safety of Dysport in patients with early onset of upper limb spasticity within 2-12 weeks after stroke
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None